Gilead Books Patent for Hepatitis C Drug Solvadi - 10.05.2016

Controller General of Patents, Designs and Trademark has granted American pharmaceutical company Gilead Sciences the patent for the blockbuster Hepatitis C drug Sofosbuvir (brand name Sovaldi) in India.

Tags : Gilead patent Sofosbuvir

Share :